Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1105174 | Transfusion Clinique et Biologique | 2013 | 11 Pages |
Abstract
Following an ABO accident after transfusion of red blood cells, an a priori risk analysis study is being performed in a hospital. The scope of this analysis covers from the reception of the blood product in the medical unit to its administration. The risk analysis enables to identify the potentially dangerous situations and the evaluation of the risks in order to propose corrective measures (precautionary or protective) and bring the system back to an acceptable risk level. The innovative concept of an a priori risk analysis in the medical field allows the extension of the analysis of this transfusion risk to other hospitals. In addition, it allows the extension of the use of this approach to other medical fields.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
E. Bertrand, R. Lévy, D. Boyeldieu,